Kynam Capital Management, LP Allakos Inc. Transaction History
Kynam Capital Management, LP
- $1.28 Billion
- Q2 2024
A detailed history of Kynam Capital Management, LP transactions in Allakos Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 74,500 shares of ALLK stock, worth $94,615. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,500Holding current value
$94,615% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ALLK
# of Institutions
96Shares Held
70.7MCall Options Held
43.8KPut Options Held
1.4K-
Bvf Inc San Francisco, CA16.6MShares$21 Million0.51% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$7.81 Million0.58% of portfolio
-
Deep Track Capital, LP Greenwich, CT5MShares$6.35 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$4.46 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.42MShares$4.35 Million0.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $108M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...